These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 17908266

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Drug challenges reveal differences in mediation of stress facilitation of voluntary alcohol drinking and withdrawal-induced anxiety in alcohol-preferring P rats.
    Overstreet DH, Knapp DJ, Breese GR.
    Alcohol Clin Exp Res; 2007 Sep; 31(9):1473-81. PubMed ID: 17624999
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sensitization, duration, and pharmacological blockade of anxiety-like behavior following repeated ethanol withdrawal in adolescent and adult rats.
    Wills TA, Knapp DJ, Overstreet DH, Breese GR.
    Alcohol Clin Exp Res; 2009 Mar; 33(3):455-63. PubMed ID: 19120055
    [Abstract] [Full Text] [Related]

  • 6. Repeated lipopolysaccharide (LPS) or cytokine treatments sensitize ethanol withdrawal-induced anxiety-like behavior.
    Breese GR, Knapp DJ, Overstreet DH, Navarro M, Wills TA, Angel RA.
    Neuropsychopharmacology; 2008 Mar; 33(4):867-76. PubMed ID: 17551540
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reduction in repeated ethanol-withdrawal-induced anxiety-like behavior by site-selective injections of 5-HT1A and 5-HT2C ligands.
    Overstreet DH, Knapp DJ, Angel RA, Navarro M, Breese GR.
    Psychopharmacology (Berl); 2006 Jul; 187(1):1-12. PubMed ID: 16767411
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Similar anxiolytic-like effects following intra-amygdala infusions of benzodiazepine receptor agonist and antagonist: evidence for the release of an endogenous benzodiazepine inverse agonist in mice exposed to elevated plus-maze test.
    Barbalho CA, Nunes-de-Souza RL, Canto-de-Souza A.
    Brain Res; 2009 Apr 24; 1267():65-76. PubMed ID: 19268657
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt.
    Savić MM, Obradović DI, Ugresić ND, Cook JM, Sarma PV, Bokonjić DR.
    Psychopharmacology (Berl); 2005 Jul 24; 180(3):455-65. PubMed ID: 15719222
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors.
    Brot MD, Akwa Y, Purdy RH, Koob GF, Britton KT.
    Eur J Pharmacol; 1997 Apr 23; 325(1):1-7. PubMed ID: 9151931
    [Abstract] [Full Text] [Related]

  • 19. SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats.
    Knapp DJ, Overstreet DH, Moy SS, Breese GR.
    Alcohol; 2004 Feb 23; 32(2):101-11. PubMed ID: 15163561
    [Abstract] [Full Text] [Related]

  • 20. Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt.
    Savić MM, Obradović DI, Ugresić ND, Cook JM, Yin W, Bokonjić DR.
    Pharmacol Biochem Behav; 2004 Oct 23; 79(2):279-90. PubMed ID: 15501303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.